Medici List

Terra Innovatum Global N.V. is a Dutch public company headquartered in Lucca, Italy developing and selling the SOLO 1 MWe micro‑modular helium‑cooled nuclear reactor for distributed power and process heat, pursuing FOAK licensing and a fabless manufacturing model.

Sonoma Pharmaceuticals, Inc. develops and commercializes stabilized hypochlorous acid (HOCl)-based medical and hygiene products (wound care, dermatology, eye care, animal health, surface disinfection), manufactures in Mexico, and sells in over 55 countries.

Pillarstone Capital REIT was a Maryland-founded (1994) publicly reporting real estate investment trust that invested in, owned and operated commercial properties (primarily office/industrial/retail) in Dallas and Houston, owned eight properties totaling ~0.9M sq ft, and entered Chapter 11 in March 2024 with a plan of liquidation completed in 2024–2025.

QUMS appears to be a special-purpose acquisition company (SPAC) that completed an IPO and holds substantial investments in a trust account; it reported net income of $978,206 for the fiscal year 2026.

Alternus Clean Energy, Inc. is a New York–headquartered holding company focused on decentralized onsite energy microgrids (integrating wind, solar and storage) delivered via its EverOn joint venture under long-term PPAs and EaaS arrangements.

Credo Technology Group is a fabless semiconductor company that designs SerDes IP and high-speed connectivity products (AECS, optical PAM4 DSPs, transceivers, chiplets, PCIe retimers and software) for data-center, AI/ML and cloud-scale interconnects.

Powerfleet provides an AIoT Unity platform that connects and manages high-value enterprise and mid-market assets, delivering SaaS-based visibility, safety, compliance, and operational insights across on-road and in-facility environments.

Canopy Growth is a global cannabis company that produces, distributes and sells medical and adult‑use cannabis products and vaporizers across multiple international markets.

Item 1 (Business) text was not provided. Based on the available financials, the company is a capital-intensive operating business with substantial property, plant and equipment and generated $46,660,320 of revenue in fiscal 2025 and a net loss of $21,596,628; core products/services, principal markets/customers, geographic footprint and headcount were not disclosed in the provided text.

Late clinical-stage Nevada-based biotech developing intranasal pherine medicines for psychiatric and neurological disorders, including a Phase 3 program for social anxiety disorder (fasedienol) and multiple Phase 2 candidates.

IEH Corporation designs and manufactures Hyperboloid PCB-style interconnect connectors and contacts for high-reliability applications across defense, aerospace, space launch, medical, oil & gas, and industrial markets.

U.S.-based global beverage alcohol company that owns and markets the Jack Daniel’s family of brands and other premium spirits, producing, marketing, and distributing products through distributors, wholesalers, and retailers.